Current status of clinical islet transplantation

Transplantation

Volumn 79, Issue 10, 2005, Pages 1289-1293

  Korsgren, Olle ^a   Nilsson, B ^a   Berne, C ^a   Felldin, M ^b   Foss, A ^c   Kallen, R ^d   Lundgren, T ^e   Salmela, K ^f   Tibell, A ^e   Tufveson, G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d University Hospital   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; REVIEW; TRANSPLANTATION TOLERANCE; TREATMENT INDICATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 21144439148     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000157273.60147.7C     Document Type: Review

References (44)

1. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 35.
2. Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72: 175.
3. Gray DW, McShane P, Grant A, et al. A method for isolation of islets of Langerhans from the human pancreas. Diabetes 1984; 33: 1055.
4. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989; 38(Suppl 1): 140.
5. Lake S, Bassett P, Larkins A, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 1989; 38(Suppl 1): 143.
6. Robertson GS, Chadwick DR, Contractor H, James RF, London NJ. The optimization of large-scale density gradient isolation of human islets. Acta Diabetol 1993; 30: 93.
7. Scharp D, Lacy P, Santiago J, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990; 39: 515.
8. Farney A, Najarian J, Nakhleh R, et al. Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis. Surgery 1991; 110: 427.
9. Carroll P, Rilo H, Alejandro R, et al. Long-term (> 3-year) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. Transplantation 1995; 59: 875.
10. Warnock G, Kneteman N, Ryan E, et al. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 89.
11. Shapiro A, Lakey J, Ryan E, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
12. Ryan E, Lakey J, Rajotte R, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
13. Ryan E, Lakey J, Paty B, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
14. Davalli A, Ogawa Y, Scaglia L, et al. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 1995; 44: 104.
15. Davalli A, Ogawa Y, Ricordi C, et al. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995; 59: 817.
16. Bennet W, Sundberg B, Groth C, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 1907.
17. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
18. Titus TT, Horton PJ, Badet L, et al. Adverse outcome of human islet-allogeneic blood interaction. Transplantation 2003; 75: 1317.
19. Saito K, Iwama N, Takahashi T. Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas. Tohoku J Exp Med 1978; 124: 177.
20. Hellman B. The frequency distribution of the number and volume of the islets of Langerhans in man: studies on non-diabetic adults. Acta Soc Med Upsal 1959; 64: 432.
21. Hellman B. Actual distribution of the number and volume of the islet of Langerhans in different size classes in non-diabetic humans of varying ages. Nature 1959; 184: 1498.
22. Brandhorst H, Brandhorst D, Brendel M, et al. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 1998; 7: 489.
23. Brandhorst H, Brandhorst D, Hering BJ, et al. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995; 103(Suppl 2): 23.
24. Linetsky E, Bottino R, Lehmann R, et al. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120.
25. Bertuzzi F, Garancini P, Socci TC, et al. Lessons from in vitro perifusion of pancreatic islets isolated from 80 human pancreases. Cell Transplant 1999; 8: 709.
26. Arita S, Une S, Ohtsuka S, et al. Increased islet viability by addition of beraprost sodium to collagenase solution. Pancreas 2001; 23: 62.
27. Matsumoto S, Rigley TH, Qualley SA, et al. Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant 2002; 11: 769.
28. Rose NL, Palcic MM, Helms LM, et al. Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation. Transplantation 2003; 75: 462.
29. Huang GC, Zhao M, Jones P, et al. The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation 2004; 77: 143.
30. Brandhorst H, Brandhorst D, Hesse F, et al. Successful human islet isolation utilizing recombinant collagenase. Diabetes 2003; 52: 1143.
31. Robertson R, Lanz K, Sutherland D, et al. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002; 73: 736.
32. Seaquist E, Kahn S, Clark P, et al. Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest 1996; 97: 455.
33. Kandaswamy R, Hering B, Sutherland D. Critical islet mass in islet autotransplantation (IaTx) after pancreas (Px) resection. Transplantation 2000; 69(Suppl):A606.
34. Gray DW. Islet isolation and transplantation techniques in the primate. Surg Gynecol Obstet 1990; 170: 225.
35. Kenyon N, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999; 96: 8132.
36. Adams A, Shirasugi N, Durham M, et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 2002; 51: 265.
37. Contreras J, Jenkins S, Eckhoff D, et al. Stable alpha- and beta-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates. Am J Transplant 2003; 3: 128.
38. Toyama H, Takada M, Suzuki Y, et al. Activation of macrophage-associated molecules after brain death in islets. Cell Transplant 2003; 12: 27.
39. Contreras JL, Eckstein C, Smyth CA, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003; 52: 2935.
40. Piemonti L, Leone B, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002; 51: 55.
41. Chen M, Proost P, Gysemans C, et al. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 2001; 44: 325.
42. Johansson U, Olsson A, Gabrielsson S, et al. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003; 308: 474.
43. De Meester J, Doxiadis I, Persijn G, et al. Renal transplantation of highly sensitised patients via prioritised renal allocation programs. Shorter waiting time and above-average graft survival. Nephron 2002; 92: 111.
44. Meier-Kriesche H, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377.